David Harrich

8PUBLICATIONS
6CO-AUTHORS
Biologically active moleculesMedical virologyMajor global burdens of diseaseBioavailability and ecotoxicologyAnimal systematics and taxonomy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 06, 2026
Turning defects into defenses: the potential and challenges of defective viral genome-based antiviral strategies.

|Nov 29, 2022
Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.

Min-Hsuan Lin, Dongsheng Li, Bing Tang

|May 12, 2021
Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity.

Dongsheng Li, Min-Hsuan Lin, Daniel J Rawle

|Oct 10, 2020
Assessing the Binding of Venoms from Aquatic Elapids to the Nicotinic Acetylcholine Receptor Orthosteric Site of Different Prey Models.

Richard J Harris, Nicholas J Youngman, Christina N Zdenek

|May 13, 2020
Evolutionary Interpretations of Nicotinic Acetylcholine Receptor Targeting Venom Effects by a Clade of Asian Viperidae Snakes.

Richard J Harris, Christina N Zdenek, Jordan Debono

|Apr 12, 2020
Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.

Hongping Jin, Dongsheng Li, Min-Hsuan Lin

Pageof 2

Frequent Collaborators

2 joint publications

Richard J Harris

2 joint publications

Christina N Zdenek

2 joint publications

Bryan G Fry

1 joint publications

Jordan Debono